SCHEMBL9463261

SCHEMBL9463261

CC(=O)Cc1cc(Br)c2c(c1)C1(C)CCN(C)C1N2C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.43
CYP2D6 P10635 3/20 0.43
TP53 P04637 2/20 0.43
ALOX15 P16050 2/20 0.43
MAPT P10636 2/20 0.43
CYP1A2 P05177 2/20 0.43
HIF1A Q16665 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MTOR P42345 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
THPO P40225 1/20 0.43
HSD17B10 Q99714 1/20 0.43
FTO Q9C0B1 1/20 0.43
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.42
BLM P54132 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9463266 0.86 KDM4E (0.43) KDM4ECYP2D6TP53ALOX15MAPT
Acetic Acid SCHEMBL8827757 0.80 KDM4E (0.53) KDM4ECYP2D6TP53ALOX15MAPT
SCHEMBL2598853 0.79 ACHE (0.50) KDM4ECYP2D6MAPTCYP1A2HIF1A
SCHEMBL2456789 0.79 KDM4E (0.59) KDM4ECYP2D6TP53ALOX15MAPT
SCHEMBL2456790 0.79 KDM4E (0.59) KDM4ECYP2D6TP53ALOX15MAPT
SCHEMBL9536827 0.79 KDM4E (0.59) KDM4ECYP2D6TP53ALOX15MAPT
SCHEMBL9463762 0.79 KDM4E (0.63) KDM4ECYP2D6TP53ALOX15MAPT
Hydrochloric Acid SCHEMBL8827744 0.78 ACHE (0.49) KDM4ECYP2D6MAPTCYP1A2HIF1A
Hydrochloric Acid SCHEMBL8827752 0.78 ACHE (0.49) KDM4ECYP2D6MAPTCYP1A2HIF1A
SCHEMBL9207689 0.78 ACHE (0.51) KDM4ECYP2D6MAPTCYP1A2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5216017-A Antishock agent, cholinergic agent; learning enhancement, alzheimer's disease HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-06-01 US disclosed
EP-0456196-A1 Pyrrolo,[2,3-b]indole-ketones and analogs, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-11-13 EP disclosed